Earnings Dashboard
VRTX
upcomingVERTEX PHARMACEUTICALS INC
Time TBDlarge capMonday, May 4, 2026
Expected Move Analysis
Expected
8.3%
Current Stock Price
$427.38
Expected Move
±8.3%
±$35.64
IV Rank
49
Moderate
Put/Call Ratio
0.70
Bullish bias
Analysis & Commentary
VERTEX PHARMACEUTICALS INC (VRTX) reports earnings Monday . Consensus EPS estimate is $3.91.
IV Rank sits at 49, indicating fairly-priced options. Neither premium sellers nor buyers have a clear structural edge here — let your directional thesis guide the trade.
A calendar spread could benefit from the front-month IV crush while maintaining exposure through the back month. Sell the weekly expiration and buy 30-45 DTE.
Enter 2-3 days before earnings. Sell the weekly expiration (front month) and buy 30-45 DTE (back month). The goal is for the front month to decay rapidly with the IV crush while the back month retains value.